Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours

In conclusion, regorafenib presents a valuable new tool in the treatment of patients with advanced GISTs following the failure of imatinib and sunitinib.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research